PGA.V - Pacgen Life Science Corporation

. Currency in USD

Pacgen Life Science Corporation

701 West Georgia Street
Suite 1500
Vancouver, BC V7Y 1C6

Full Time Employees

Key Executives

Mr. Chung-Yu Wang B.Sc., EMBA, Ph.D.Co-Founder, Chairman and Interim Chief Exec. OfficerN/AN/A71
Ms. Christina Yip MBA, BBA (Honours), CPA, CMAPres, Chief Financial Officer, Sec. and DirectorN/AN/A52
Ms. Julie P. RezlerVP of Corp. Devel.N/AN/AN/A
Amounts are as of December 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in .


Pacgen Life Science Corporation, a life science company, focuses on commercializing life sciences products and services. It engages in the development, commercialization, and licensing of PAC-113, an antifungal that contains 12 amino-acid antimicrobial peptide derived from naturally occurring protein found in human saliva for the treatment of oral diseases, such as oral cavity, oral candidiasis, and esophagus infection. The company was formerly known as Pacgen Biopharmaceuticals Corporation and changed its name to Pacgen Life Science Corporation in May 2012. Pacgen Life Science Corporation was founded in 2004 and is headquartered in Vancouver, Canada.

Corporate Governance

Pacgen Life Science Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.